I kappa B beta but not I kappa B alpha, functions as a classical cytoplasmic inhibitor of NF-kappa B dimers by masking both NF-kappa B nuclear localization sequences in resting cells

NF-kappaB dimers, inhibitor I kappaB proteins, and NF-kappaB .I kappaB comp lexes exhibit distinct patterns in partitioning between nuclear and cytopla smic cellular compartments. I kappaB-dependent modulation of NF-kappaB subc ellular localization represents one of the more poorly understood processes in the NF-kappaB signaling pathway. In this study, we have combined in vit ro biochemical and cell-based methods to elucidate differences in NF-kappaB regulation exhibited by the inhibitors I kappaB beta and I kappaB alpha. W e show that although both I kappaB alpha and I kappaB beta bind to NF-kappa B with similar global architecture and stability, significant differences e xist that contribute to their unique functional roles. I kappaB beta derive s its high affinity toward NF-kappaB dimers by binding to both NF-kappaB su bunit nuclear localization signals. In contrast, I kappaB alpha contacts on ly one NF-kappaB NLS and employs its carboxyl-terminal proline, glutamic ac id, serine, and threonine-rich region for high affinity NF-kappaB binding. We show that the presence of one free NLS in the NF-kappaB .I kappaB alpha complex renders it a dynamic nucleocytoplasmic complex, whereas NF-kappaB . I kappaB beta complexes are localized to the cytoplasm of resting cells.